INTRODUCTION
Dosage forms are designed to deliver optimum dose of drug to the site of action to produce desired pharmacological action and also to achieve the effective drug concentration over the preferred period of time. Oral drug delivery system is the most commonly used route of administration when compared to all other routes for various pharmaceutical products of different dosage forms. Easy administration, high patient compliance, avoiding tough sterile standards, and relatively cheap and easy formulation makes the oral dosage form as the first priority (Krishnaiah et al., 2002) .Verapamil Hydrochloride, a commonly used calcium channel blocker for hypertension and arrhythm ias, has a biological half-life of 4 to 6 hours. It has quite good absorption profile from gastrointestinal tract; about 90% of the orally administered drug is absorbed from the gastro intestinal tract. However, it undergoes extensive first pass metabolism which results in only 20% bioavailability. Keeping in view these facts, formulating a controlled release dosage form for Verapamil Hydrochloride is gaining interest to increase the therapeutic efficacy and patient compliance (Sahoo et al., 2009) . Matrix tablets can be formulated by using natural polymers by direct compression of the mixture of active ingredient, retardant material and additives. The hydrophilic matrix needs water to activate the release mechanism and several benefits including ease of manufacture, release of 100% drug in-vivo and outstanding uniformity of matrix tablets. The hydrophilic matrix tablets are immersion in water swiftly forms a gel layer around the tablets (Shah et al., 2012) .
Aims and objectives of the present study are to formulate the sustained release matrix tablets of Verapamil Hydrochloride using natural polymers (Tragacanth and Pectin) by direct compression method. Natural polymers exhibit good drug release retarding behavior and are biocompatible & economic. Release retarding behavior of natural polymers in matrix formulations is compared to that of marketed product Calan SR taken as reference tablet.
MATERIALS AND METHOD

Materials
Verapamil Hydrochloride used as a model drug was gifted by Searle Pakistan Ltd. Microcrystalline cellulose (diluent), aerosil (glidant), magnesium stearate (lubricant) and polymers (release retarding materials) Pectin and Tragacanth were obtained as a gift from Unexo Pharma (pvt.) Ltd. Lactose was obtained from E Merck Germany. Chemicals like hydrochloric acid, sodium hydroxide, potassium dihydrogen phosphate were obtained from Mega Pharmaceuticals (pvt.) Ltd.
Methods
Milling of all ingredients was conducted to reduce the particle size then all the ingredients were passed through sieve no. 60. Verapamil hydrochloride was mixed with different polymers (individually as well as different combination forms) one by one in different drug to polymer ratios 1:0.5, 1:1, 1:1.5 and 1:2. Eight different Verapamil Hydrochloride -polymer combinations were
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made as shown in (table 1) , which were then mixed with PVP, Aerosil and lactose in a poly bag and the mixture was again passed through a mesh no. 60. Magnesium Stearate was added to the blend. Twenty different blends thus obtained were weighed individually for weightequivalent to 850 mg/ tablet and then were compressed into tablets on a single punch tablet machine.
Pre-compression studies
Angle of repose Blend of powder was added to a funnel that was vertically placed to obtain a max height (H) cone. Radius of heap (R) was noted and (Ө) angle of repose was calculated as (Marshal, 1987) .
Bulk density
Drug and excipients mixture was sieved and then put in the graduated cylinder .The volume and weight of powder was determined (Marshal, 1987) .
Bulk density= weight of powder/volume of powder
Tapped density
The tapped density was determined by tapping the cylinder having pre-weighed powder and then tapped it 100 times (Marshal, 1987) .
Db = W/Vb
Db = loose bulk density, W = weight of powder, Vb = volume of powder
Carr's index
The free flowing of powder was measured by compressibility index i.e. a property with which material would flow easily (Marshal, 1987 ).
Carr's index (I) = (Vb-Vt) x 100 /Vb
Hausner ratio It is indirect method for measuring ease of powder flow (Marshal, 1987 ).
Hausner's ratio = Dt/Db
DSC studies
The DSC analysis of pure drug, polymers and there mixture was conducted on SDT. Q600 TA USA to check any possible interactions. Drug, polymers and there combinations were triturated to make them fine in size and then heated in sealed Aluminium pan at a heating rate of 10°C/min from 0 to 210°C. The nitrogen flow was 40ml/min. Reproducibility was checked by running sample in triplicate (Ranjha et al., 2010) .
Post-compression studies
Compressed tablets were evaluated by different param eters, including appearance, thickness and diameter, weight variations, hardness, percent friability and contents uniformity (Patel et al., 2012) .
Dissolution studies
Dissolution studies of Verapamil Hydrochloride tablets were investigated in USP tablet dissolution test apparatus-II (Paddle apparatus) at 50 rpm. 900 ml of pH 6.8 phosphate buffer was used as a dissolution medium. An already warmed to 37±0.5°C dissolution medium was used and its temperature was maintained during the complete time of experiment. Five ml of the sample of dissolution medium was taken using syringe at specified time intervals (1 hour).
The volume withdrawn at each interval was replaced with same quantity of fresh dissolution medium. The sample was analyzed for drug release by measuring the absorbance at 278 nm using UV-visible spectrophotometer after suitable dilutions and filtration.
Statistical analysis
Statistical analysis was done to calculate the standard deviation and mean of different parameters. Different kinetics modes were applied including; Zero Order Kinetics (Qt= ko t)………………………… 1 First Order Kinetics (log Qt= log Qo -k1 t)…………. 2 Highuchi Model (Qt = kH t 1/2 )………………………… 3 KorsmeyerPeppas Model (Mt / M∞ = kKFt n )…………. 4
These models were utilized in the prediction of drug behavior and release kinetics (Sahoo et al., 2009) . Similarity (f2) and difference (f1) factors were also calculated by the following equations Gohel et al., 2002) .
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RESULTS
Pre-compression studies
All the results of angle of repose, bulk density, tapped density; Carr's compressibility index and Hausner's ratio were found within the limits indicating good flow properties of powder to be compressed as shown in (table 2) . Differential scanning calorimetery (DSC) was performed for all the polymers and drug alone and in combination, no compatibility issue was revealed from spectra as shown in (figure 1). 
Standard calibration curve for Verapamil hydrochloride
Standard calibration curve was plotted for Verapamil Hydrochloride was plotted by taking concentration in mcg/ml and measuring their absorbance at UV-visible Spectrophotometer. The standard calibration curve obtained was a straight line, which proved that the drug in the concentration range of 10-80 mcg/ml, obeyed the Beer's Lambert law as shown in (figure 2).
Dissolution studies
Formulations F1-F4 formulated with tragacanth showed 100, 100, 98.25 and 96.48% drug, respectively in 12 hours studies as shown in (figure 3). Formulations F5-F8 formulated with Pectin released 100, 99.37, 87.14 and 84.15% of the drug respectively in 12 hours (figure 4). (table 4) .
Kinetics modeling of the release data
Similarity index
Values of similarity factor (f2) were found to be greater than 50 in all formulations except F7 and F8. Similarly the difference factor (f1) ≤10 for all the formulations except F7 and F8 as shown in (table 5 ). 
DISCUSSIONS
Results of the thickness test and diameters were with minimal variations found to be uniform. Weight variations for formulations comply with the official limits ± 5. Formulation F4 showed least hardness value 5.7 kg/cm 2 . Hardness, % friability and drug contents of all the formulated tablets of verapamil hydrochloride complies with the official limits of 4-10 kg/cm 2 ,less than 1% and 95-105%respectively as per BP. Formulation trials having least polymer ratios showed least release retarding behavior, but as the ratio of polymer to drug was increased, release retarding behavior also increased significantly. F4 Formulation having drug to polymer ratio 1:2, showed satisfactory sustained release behavior comparable to that of marketed product Calan SR. Release retarding behavior of drug in F7 & F8 is much significant as compared to Calan SR but it did not comply with the official limits of USP. As the drug to polymer ratio was increased the similarity between F1 to F4 also increased but the formulation F3 showed some anomalous behavior. Although Formulation F3 is similar to marked product Calan SR, but the similarity factor value is less as compared to the formulation F1, F2 & F4. Formulation F4 was the most similar formulation to that of the reference standard. Formulation F5 showed maximum similarity with reference formulation. With the increase of polymer concentration, release retarding behavior increased. Although F6, F7, F8 were more sustained than reference formulation, but similarity factor value decreased with the increase of drug to polymer ratios. Release of the drug was observed to be influenced by the polymer concentration as, polymers concentration increased the release of the drug decreased (Patel et al., 2012) . Both tragacanth and pectin were the hydrophilic polymers. Initially there was greater release was observed because less hydration of the polymer but when the polymers in the tablets got hydrated release of the drug became slow gradually (Patel et al., 2012; Shah et al., 1998) . Pectin became swell after the absorption of the aqueous media (Shah et al., 2011) . Slow release was observed in the formulations containing pectin because of the formation of gel layer around the tablets which can decrease the rate of erosion of the tablets (Sriamornsak et al., 2007) . Higher values of Higuchi model showed that drug release pattern was according to diffusion, which was usually observed in the matrix systems formulated with the natural hydrophilic polymers. Diffusional exponent value (n) of Pappas model for formulation trials F1-F2 showed quasi Fickian type of diffusion. Drug to polymer ratio in these formulations was 1:0.5 and 1:1 respectively. Polymer used in F1 to F4 formulations was pectin in different drug to polymer ratios. 
